Related Experiment Videos
Cancer Pain Management and Bone Metastases: An Update for the Clinician
Guido Schneider1, Raymond Voltz, Jan Gaertner
1Department of Palliative Care, University Hospital Cologne, BMBF 01KN1106, Germany.
Breast Care (Basel, Switzerland)
|June 29, 2012
Summary
Managing cancer pain in breast cancer patients with bone metastases requires optimal opioid therapy, including breakthrough pain management and addressing constipation. Palliative care and multimodal approaches are crucial for comprehensive patient well-being.
Area of Science:
- Oncology
- Pain Management
- Palliative Care
Background:
- Breast cancer with bone metastases frequently causes significant cancer pain, often inadequately managed.
- Current treatment strategies for cancer pain are suboptimal for many patients.
- Opioid analgesics are central to cancer pain management, with morphine as a first-line therapy.
Purpose of the Study:
- To review current pharmacologic and non-pharmacologic strategies for managing cancer pain in breast cancer patients with bone metastases.
- To highlight the importance of individualized treatment approaches considering pain type and patient condition.
- To emphasize the role of palliative care in addressing total pain, including psychosocial and existential suffering.
Main Methods:
- Review of current literature and clinical guidelines on cancer pain management.
- Discussion of various pharmacologic options, including opioids, non-opioid analgesics, and co-analgesics.
- Exploration of non-pharmacologic interventions such as radiotherapy and radionuclid therapy.
Main Results:
- Morphine remains the gold standard, with other pure μ agonists (hydromorphone, fentanyl, oxycodone) as alternatives.
- Transdermal opioids are useful when oral administration is not feasible.
- Combination therapy (e.g., oxycodone/naloxone) can mitigate opioid-induced constipation.
- Breakthrough pain requires on-demand opioids, with rapid-onset fentanyl formulations showing promise.
- Radiotherapy is effective for localized bone pain, while radionuclids may benefit diffuse pain.
- Glucocorticoids and co-analgesics (e.g., pregabalin) are important for advanced stages and neuropathic pain, respectively.
Conclusions:
- Optimal cancer pain management involves a multimodal approach, including pharmacologic and non-pharmacologic interventions.
- Addressing breakthrough pain and opioid-induced side effects is critical.
- Palliative care integration is essential for managing the holistic needs of patients with incurable cancer pain.
- A multiprofessional palliative care approach is recommended for comprehensive management of «total pain».
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...